Endocrinology News

ORLANDO — The generic lipid-lowering drug fenofibrate was associated with a significant reduction in progression of diabetic retinopathy and maculopathy, researchers reported.

ORLANDO — Continuous glucose monitoring metrics can predict imminent stage 3 type 1 diabetes for people who are islet autoantibody positive, according to a speaker at the American Diabetes Association Scientific Sessions.

ORLANDO — In this video exclusive, Osagie Ebekozien, MD, MPH, CPHQ, chief medical officer at T1D Exchange, talks about a victory in increasing access to continuous glucose monitors.

ORLANDO — Health care inequities led to some children and adolescents starting continuous glucose monitoring more than 6 months after a type 1 diabetes diagnosis, according to data presented here.

ORLANDO — In this video exclusive, Osagie Ebekozien, MD, MPH, CPHQ, chief medical officer at T1D Exchange, describes how the organization is moving research into practice.

ORLANDO — Adults with obesity who reduce their body weight lower their odds for developing an obesity-related cancer, according to data presented at the American Diabetes Association Scientific Sessions.

ORLANDO — An inhaled insulin was noninferior to usual care for change in HbA1c and continuous glucose monitoring metrics among adults with type 1 diabetes, according to data from the INHALE-3 trial.

ORLANDO — Race-conscious medicine can help to identify those at higher risk for prediabetes and diabetes; however, this method can exacerbate racism and impede health equity, according to two speakers.

ORLANDO — The GIP/GLP-1 dual agonist tirzepatide reduced symptoms of obstructive sleep apnea and improved multiple cardiometabolic markers for adults with obesity and obstructive sleep apnea, according to data from the SURMOUNT-OSA trial.

“I’ve always wanted to be a doctor,” Samuel Dagogo-Jack, MD, DSc, this year’s recipient of the American Diabetes Association’s Outstanding Achievement in Clinical Diabetes Research Award, told Healio.